7.3.2022
News
M&A
TMT

Solitea Continues To Acquire Businesses in 2022

After two years of negotiations, Solitea has successfully closed one of its largest deals and acquired a 100% stake in Techniserv IT, a leading Czech software company that provides large software solutions to large organizations and government agencies (such as the Czech Railways Group, the Czech General Customs Directorate, the Ministry for Regional Development, and the Brno Magistrate).

KSB's team led by Drahomír Tomašuk and Ján Béreš assisted in the transaction by carrying out extensive due diligence and drafting and negotiating the transaction documentation.

Details are available in Solitea's press release here here and in the general media, such as here and here.

Other articles

8.7.2025
News

Advising J&T on the preparation of another bond programme – the Europacity Berlin project.

KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
News

A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein

Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
News

KŠB advised the seller on the sale of mcePharma to the Brenntag Group

The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.